Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma-Reference-Cited by-同舟云学术

Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma

Published:2021-03 Issue: Volume:20 Page:166-174
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Wirsching Hans-Georg^ORCID,Silginer Manuela,Ventura Elisa,Macnair Will,Burghardt Isabel,Claassen Manfred,Gatti Silvia,Wichmann Jürgen,Riemer Claus,Schneider Hannah,Weller Michael

Funder

Swiss Life Stiftung für Chancenreichtum und Zukunft

Roche

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference40 articles.

1. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas;Weller;Lancet Oncol.,2017

2. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012;Ostrom;Neuro-oncol.,2015

3. An integrative model of cellular states, plasticity, and genetics for glioblastoma;Neftel;Cell,2019

4. Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq;Filbin;Science,2018

5. Cancer stem cells in glioblastoma;Lathia;Genes Dev.,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabotropic Glutamate Receptors Type 3 and 5 Feature the “NeuroTransmitter-type” of Glioblastoma: A Bioinformatic Approach;Current Neuropharmacology;2024-09

2. Genetic estimates and genome-wide association studies of antibody response in Tanzanian dairy cattle;2024-08-08

3. Neurosteroids in Glioma: A Novel Therapeutic Concept;Life;2024-08-02

4. A glutamatergic biomarker panel enables differentiating Grade 4 gliomas/astrocytomas from brain metastases;Frontiers in Oncology;2024-05-21

5. Challenges in glioblastoma research: focus on the tumor microenvironment;Trends in Cancer;2023-01